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Abstract 15
The first large-scale urban survey of Giardia infections in dogs was undertaken in the  16
USA. It involved several locations in the Western United States with Giardia isolates  17
from microscopy-positive samples characterized by multi-locus PCR and sequencing.   A  18
high prevalence of Giardia was confirmed in asymptomatic domestic dogs, and for the  19
first  time,  provides  evidence  that  zoonotic  assemblages/subgroups  of  Giardia  occur  20
frequently in domestic dogs living in urban environments, and more frequently than the  21
dog specific assemblages. 22
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Introduction 26
27
There is increasing evidence globally that infections with Giardia occur frequently in  28
domestic dogs, and that it is often the most common enteric parasite of dogs in developed  29
countries  (Thompson  et  al.  2008;  Scaramozzino  et  al.  2009;  Ballweber  et  al.  2010).  30
Prevalence  rates  vary  and  are  influenced  by  the  sampling  strategies  and  diagnostic  31
methods used (Epe et al. 2010). Although Giardia may be associated with gastrointestinal  32
disorders in dogs (Barutzki et al. 2007; Epe et al. 2010), most concern has been directed  33
to the public health significance of such infections since Giardia is potentially zoonotic  34
(Thompson 2004; Caccio et al. 2005; Leonhard et al. 2007; Sprong et al. 2009; Ballweber  35
et al. 2010).   36
37
Prevalence rates on their own are insufficient to gauge the public health risks of canine  38
Giardia  infections  without  data  on  the  genotypes  of  Giardia  that  occur  in  dogs.  G.  39
duodenalis (G. intestinalis) is the most frequent form of Giardia found in mammals and  40
represents a species complex comprising genotypes/assemblages that are host specific,  41
and  those  that  affect  humans  and  a  range  of  other  mammalian  species  and  are  thus  42
considered  to  have  zoonotic  potential  (Monis  et  al.  2009).  Dogs  are  susceptible  to  43
infection  with  assemblages  C  and  D  which  are  considered  to  be  specific  for  dogs  44
(Hopkins et al. 1997; Monis et al. 1998; Thompson 2004), while assemblage F seems to  45
be specific for cats, E for livestock (Ey et al. 1997) and G for rats (Monis et al. 1999). In  46Page 3 of 20
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contrast, assemblages A and B affect humans but are not human-specific and infect a  47
wider host range including dogs, cats, livestock and wildlife and are potentially zoonotic.  48
Assemblages A and B show genetic sub-structuring and some subgroups appear to have  49
more zoonotic potential than others (Monis et al. 2009; Sprong et al. 2009). 50
51
Molecular epidemiological studies have been undertaken in different parts of the world  52
and although these have demonstrated that dogs may be infected with zoonotic and/or  53
dog-specific assemblages of Giardia, it is not possible to extrapolate from one area to  54
another with respect to the public health risk of canine Giardia infections. The frequency  55
of infection with zoonotic assemblages is generally more common in household dogs  56
than in dogs from kennels (Leonhard et al. 2007; Claerebout et al. 2009; Scaramozzino et  57
al. 2009). However, surveys of household dogs have demonstrated differences between  58
geographical  areas,  with  prevalences  of  infection  with  zoonotic  genotypes  varying  59
between 5.5% (Australia), 61% (Thailand), 80.5% (Belgium), 87% and 6.1% (Germany)  60
and 30.8% (Italy) (rev. in Leonhard et al. 2007; Ballweber et al. 2010). The reasons for  61
this  variability are not  clear but  emphasise the need to  undertake studies  in different  62
geographical areas. 63
64
The  public  health  significance  of  Giardia  infections  in  dogs  in  the  USA  has  been  a  65
subject of concern and controversy for many years yet only one small survey has been  66
published, in which isolates of Giardia from 15 domestic dogs in Atlanta were all shown  67
to belong to assemblage D (Sulaiman et al. 2003). The results of this study are surprising  68
in light of the more recent study by Vasilopulos et al. (2007) which examined 250 cats  69Page 4 of 20
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from Mississippi and Alabama, USA, and of 17 positive for Giardia found 6 infected  70
with Assemblage A-I and 11 with Assemblage F (the cat specific genotype), emphasising  71
the need for additional genotyping studies with larger sampling sizes to be undertaken on  72
dogs in the USA.  73
74
Therefore  the  aim  of  the  present  study  was  to  determine  the  frequency  of  Giardia  75
assemblages in dogs presented at veterinary clinics for health screening in the Western  76
United  States  where  Giardia  testing  incidence  is  the  highest  recorded  (ANTECH  77
Diagnostics data on file).  78
79
Materials and Methods 80
81
Sampling strategy 82
83
Samples  positive  for  Giardia  by  microscopy  were  obtained  from  238  healthy  dogs  84
presenting for an annual check-up at veterinary clinics in the Western United States. The  85
238 samples for this study were chosen at random on various days in 2009 during which  86
a total of 519,585 faecal samples were submitted and screened at ANTECH laboratories  87
of which 35,172 (6.8%) were positive by microscopy for Giardia (ANTECH Diagnostics  88
data  on  file  and  available  from  David.Aucoin@vcaantech.com).  All  dogs  were  89
considered asymptomatic for Giardia infection by the veterinarian on duty.  90
91
DNA extraction 92Page 5 of 20
Accepted Manuscript
5
DNA was extracted from faecal samples preserved in ethanol using the Maxwell® 16  93
Tissue DNA Purification Kit (Promega, Madison, USA) with the Maxwell® 16 SEV  94
Instrument (Promega). In addition to the recommended protocol, 1 l of the final elution  95
was  further  diluted  by  adding  4  l  of  Water-ultra  pure  grade  (Fisher  Biotech  Perth,  96
Australia). All PCR reactions were run prior to freezing the extracted DNA. 97
Amplification of 18S rRNA gene 98
PCR reactions used 2 l of the diluted DNA template, 2.5 μl of 10 X Reaction Buffer,  99
2.5 μl  of  MgCl2  (25 mM),  0.15 μl  Taq-Ti  hot  start  DNA  polymerase (Fisher Biotech  100
Perth, Australia), 1 μl of dNTPs (5 mM) (Promega), 1 μl of each primer (10 μM), 5%  101
dimethyl  sulfoxide  (DMSO)(Sigma-Aldrich  St.  Louis,  Missouri)  and Water-ultra pure  102
grade, to a final volume of 25 μl. The first-round PCR conditions were: 96°C for 5 min  103
for 1 cycle, 96°C for 45 s, 50°C for 30 s and 72°C for 45 s for 35 cycles followed by  104
72°C  for  7 min.  The  forward primer  RH11,  5′- CATCCGGTCGATCCTGCC -3′  and  105
reverse  primer  RH4,  5′- AGTCGAACCCTGATTCTCCGCCAGG -3′  were  from  106
Hopkins et al. (1997). Two micro liters from the first-round PCR reaction was used in the  107
second-round  PCR.  Second-round  PCR  conditions  were:  96°C  for  5 min  for  1 cycle,  108
96°C for 45 s, 55°C for 30 s and 72°C for 45 s for 35 cycles followed by 72°C for 7min  109
with  PCR  primers  forward  GiarF,  5′- GACGCTCTCCCCAAGGAC -3′  and  reverse 110
primer GiarR, 5′- CTGCGTCACGCTGCTCG -3′ (Read et al. 2004). DMSO was used in  111
the first round PCR only. Ultrapure Bovine Serum Albumin (BSA) Non-Aceylated was  112
added to the second round PCR (1% [50mg/mL]).  113
Amplification of β-giardin gene  114Page 6 of 20
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PCR reactions used 2 l of the diluted DNA template, 2.5 μl of 10 X Reaction Buffer,  115
2.5 μl of MgCl2 (25 mM), 0.15 μl Tth Plus DNA polymerase (Fisher Biotech Perth,  116
Australia), 1 μl of dNTPs (5 mM) (Promega), 1 μl of each primer (10 μM) and Water- 117
ultra pure grade (Fisher Biotech Perth, Australia), to a final volume of 25 μl. The first- 118
round PCR conditions were: 95°C for 5 min for 1 cycle, 95°C for 30 s, 50°C for 30 s and  119
72°C for 60 s for 40 cycles followed by 72°C for 7 min. The forward primer G7 5′- 120
AAGCCCGACGACCTCACCCGCAGTGC -3′ and reverse primer G759 5′- 121
GAGGCCGCCCTGGATCTTCGAGACGAC -3′ were from Cacciò et al. (2002). Two  122
micro liters from the first-round PCR reaction was used in the second-round PCR.  123
Second-round PCR conditions were: 96°C for 5 min for 1 cycle, 96°C for 45 s, 55°C for  124
30 s and 72°C for 45 s for 35 cycles followed by 72°C for 7min with PCR primers  125
forward: 5′- GAACGAACGAGATCGAGGTCCG -3′ and reverse: 5′- 126
CTCGACGAGCTTCGTGTT -3′, Lalle et al. (2005). 127
Amplification of Glutamate Dehydrogenase gene (GDH) 128
PCR reactions used 2 l of the diluted DNA template, 2.5 μl of 10 X Reaction Buffer,  129
2.5 μl of MgCl2 (25 mM), 0.2 μl Tth Plus DNA polymerase (Fisher Biotech Perth,  130
Australia), 1 μl of dNTPs (5 mM) (Promega), 1 μl of each primer (10 μM) and Water- 131
ultra pure grade (Fisher Biotech Perth, Australia), to a final volume of 25 μl. The first- 132
round PCR conditions were: 94°C for 5 min for 1 cycle, 94°C for 30 s, 50°C for 30 s and  133
72°C for 60 s for 40 cycles followed by 72°C for 7 min. Two micro liters from the first- 134
round PCR reaction was used in the second-round PCR. Cycling conditions for second- 135
round PCR were: 94°C for 5 min for 1 cycle, 94°C for 30 s, 60°C for 30 s and 72°C for  136Page 7 of 20
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60 s for 40 cycles followed by 72°C for 7 min. The primers for the first round PCR,  137
GDHeF, 5’- TCAACGTYAAYCGYGGYTTCCGT -3’and GDHiR 5’- 138
GTTRTCCTTGCACATCTCC -3’ as well as the primers for the second PCR reaction  139
GDHiF 5’- CAGTACAACTCYGCTCTCGG -3’ and GDHiR were from Read et al.  140
(2004). 141
Sequencing 142
PCR products were purified using a Wizard SV gel and PCR Clean-up system (Promega,  143
Madison, USA) as per the manufacturer’s instructions except for the final elution which  144
was  reduced  from  the  recommended  50  µl  to  20  µl-30  µl.  Sequence  reactions  were  145
performed  using  the  Big  Dye  Terminator  Version  3.1  cycle  sequencing  kit  (Applied  146
Biosystems) according to the manufacturer’s instructions. PCR products were sequenced  147
with  the  second  round  primers  (1µl  [10 μM]).  The  cycling  conditions  for  nucleotide  148
sequencing: 1 cycle of 96°C for 2 min and 25 cycles at 96°C for 10 s, 60°C for 5 s and  149
60°C  for  4 min.  All  PCR  and  sequencing  reactions  were  run  on  a  TaKaRa  Thermal  150
Cyclier Dice™ Version III. Reactions were electrophoresed on an ABI 3730 48 capillary  151
machine.  152
Sequences  were  analysed  and  contigs  of  nucleotide  sequences  were  made  using  153
Sequencher 4.8 (Gene Codes, Ann Arbor, MI, USA). Sequences were compared with  154
sequences  in  GenBank  by  BLAST  searches  (http://www.ncbi.nlm.nih.gov/BLAST/,  155
Altschul  et  al.  1997).  In  addition  to  the  BLAST  search,  sequences  were  aligned  in  156
sequencher with sequences from GenBank with known sub-assemblage information to  157Page 8 of 20
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confirm  the  sub-assemblage  genotype  and  to  determine  the  presence  of  multiple  158
genotypes (Table 1).  159
160
Results 161
162
Of the 238 samples that were found microscopy positive in ANTECH laboratories prior  163
to shipment to Australia, 148 were positive by PCR, of which 128 samples provided  164
interpretable sequence data. Of these 128 samples, it was possible to identify a total of  165
296  Giardia  infections of  which  15%  were  assemblage  C,  16%  assemblage  D,  28%  166
assemblage A, and 41% assemblage B (Figure 1, Table 2).  167
168
Multiple genotypes were amplified from 83% of the 128 samples. Results for 57% of the  169
multiple  genotypes  were  from  two  or  more  loci,  25%  of  these  amplifications  from  170
different loci provided the same genotype result. Sub-genotypes identified with the β- 171
giardin  gene  were  from  assemblage  A,  sub-genotypes  A2,  A3,  A5,  A8,  and  for  172
assemblage B, B1, B2, B3 and B4 (Table 2). 173
174
18S preferentially amplified assemblages B, D and C whereas β-giardin preferentially  175
amplified assemblages A, B (Table 2). β-giardin appeared to be more sensitive  176
amplifying single and multiple infections (Figure 1). The glutamate dehydrogenase gene  177
(GDH) provided limited results with genotype information for only 17 samples (Table 2).  178
179
180Page 9 of 20
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181
Discussion 182
183
The  present  study  is  the  first  large-scale  urban  survey  of  Giardia  infections  in  dogs  184
undertaken in the USA. It involved several locations in the Western United States and has  185
not only confirmed the high prevalence of Giardia in asymptomatic domestic dogs, but  186
has also shown, for the first time, that zoonotic assemblages/subgroups occur frequently  187
in domestic dogs living in urban environments, and more frequently than the dog specific  188
assemblages. 189
190
Multiple infections with zoonotic assemblages were most common, followed by mixed  191
infections with zoonotic and dog assemblages, followed by single infections with B, C or  192
D (Table 2). The results from this study emphasize that it is not possible to extrapolate  193
from  one  geographical  region  to  another  in  terms  of  the  prevalence  or  assemblage  194
composition of Giardia infections in dogs. These results thus support the global picture  195
for Giardia in dogs compiled by Ballweber et al. (2010). Furthermore, our study found a  196
higher frequency of Giardia infections with assemblage B than assemblage A, which has  197
not been reported elsewhere. This suggests that in North America at least, we cannot  198
assume that, as in Europe (Sprong et al. 2009) assemblage B has a predominantly human  199
distribution. We also found the β-giardin subgroups, A2, A3, B1, B3 and B4 in dogs,  200
which have been reported previously in humans (Lalle et al. 2005) but not before in dogs,  201
thus highlighting their zoonotic potential. 202
203Page 10 of 20
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The  high  frequency  of  multiple/mixed  infections  found  in  this  study  has  been  204
increasingly reported from multilocus studies in other countries in both humans and dogs  205
(e.g., Hussein et al. 2009; Sprong et al. 2009). This may be due to meiotic recombination  206
or preferential amplification of one assemblage over another in mixed infections (Caccio  207
et al. 2005, Cooper et al. 2007, Teodorovic et al. 2007, Weilinga and Thompson, 2007;  208
Lasek-Nesselquist et al. 2009). As regards true mixed infections, it raises the question as  209
to their source. It is possible that some infections are more commonly acquired as puppies  210
(e.g. the dog assemblages) and others possibly later in life as contact with other potential  211
hosts,  both  dog and human, increases, as does exposure to varied environments. The  212
occurrence  of  mixed  infections  also  raises  the  intriguing  question  of  how  long  do  213
individual  infections  persist  and  whether  one  assemblage  may  eventually  outcompete  214
another? 215
216
Of the 238 samples that were found microscopy positive in ANTECH laboratories prior  217
to shipment to Australia, 148 were positive by PCR, of which 128 samples provided  218
interpretable sequence data. The lower number of PCR-positives compared to microscopy  219
is probably a result of the poor condition of some samples following shipment. PCR- 220
inhibition is also a possible reason for unsuccessful amplification, however, in this study  221
DNA was extracted using the Maxwell® 16 SEV Instrument (Promega) with the final  222
elution further diluted to dilute the inhibitors. This method was successful when tested on  223
known positive samples in our laboratory.  224
225
Although PCRs for three loci were run on all samples, the glutamate dehydrogenase gene  226Page 11 of 20
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provided limited results with genotyping data for only17 samples. Amplification of the  227
18S locus is robust and useful for determining the presence or absence of an infection, the  228
short sequence does not provide sub-assemblage information, in contrast to β-giardin  229
appeared to be more sensitive in amplifying single and multiple infections (Figure 1). We  230
considered that all genotypes amplified were present in an individual sample whether it  231
was supported or differed to another locus. We could not determine if the difference in  232
the genotypes from the different loci was due to sensitivity or preferential amplification  233
of a loci. 234
235
236
The results demonstrate that a significant proportion of asymptomatic dogs in urban areas  237
of the USA harbour zoonotic Giardia, and should therefore be considered a potential  238
reservoir for infection in humans. All assemblages can be transmitted in cycles where  239
only dog to dog transmission occurs, but humans may be involved in a zoonotic cycle of  240
transmission with assemblages A and B, either contracting infection from dogs, or acting  241
as a source of infection for dogs. 242
243
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342
Table 1. GenBank accession numbers for contigs for the three loci. 343
344
18S rRNA gene β-giardin gene Glutamate dehydrogenase gene
AF199443-D AY072728-B AF069059-B111
AF199444-F AY545643-A AY178750-BIV
AF199445-A1 AY545645-A11 AY826193-B
AF199446-A11 AY545646-C DQ414242-A1
AF199447-B (111) AY545648-D L40510-A11
AF199448-E AY545649-A1 U60982-C
AF199449-C AY545649-A8 U60986-D
AF199450-G AY647266-B
DQ157272-E DQ466724-30-A1
M54878-A1 EU189375-E
U09491-B FJ009206-C
U09492-B P201207-A2
345
346
347
348
349
350
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Table 2. Assemblage and Sub-assemblage information for 128 samples for one, two or  352
three loci. 353
18S GDH ß giardin 18S and GDH 18S and ß giardin  18S, GDH and ß giardin
B (8) C (5) A2, A5 (1) B, C/D - C/D (1) B - A2 (2) B - C - A2 (1)
B, C/D (1) A2, B1 (6) B - C (9) B - A2, B1 (1)
B, D (1) A2, B3 (4) B/C - B/C (1) B - A5, B3 (1)
C (3) A2, B4 (9) B/C – C (1) B - B (1)
C/D (1) A3, B1 (2) B - B1 (2)
A3, B4 (1) B - D (1)
A5, B3 (1) B, C/D - B (1)
A5, B4 (2) C - A2 (1)
A8, B1 (1) C - A2, B1 (2)
A8, B2 (1) C - A2, B4 (3)
A8, B4 (1) C - A3, B4 (2)
B1 (3) C - A5, B4 (1)
B1, A2 (2) C - A8, B3 (1)
B1, A8 (1) C - D (1)
B1, B3 (1) C - D/C, A2 (1)
B4, A5 (1) C/D - A2, B3 (1)
B, A3 (1) C/D - C/D, B3 (1)
C, A2, B1 (1) D - A2, B3 (9)
C, A2, B4 (1) D - A2, B4 (7)
D (2) D - A3, B4 (1)
D, A2, B3 (1) D - A5, B3 (1)
D, A2, B4 (1) D - A8, B2 (1)
D, A3, B3 (1) D - A8, B3 (1)Page 18 of 20
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D, A3, B4 (1) D - B1 A2 (1)
D, A8 (1) D - B1, B3 (1)
D, A8, B3 (1) D - C, A2, B4 (1)
D, B1 (1) D - D, B A2 (1)
Results in the columns labelled with the single locus are from samples which only  354
amplified at this locus, for example the 18S column has results for 14 samples, which  355
only amplified, at this locus (18S) and the GDH column has results for five samples  356
which only amplified for GDH. Columns with two and three loci have results for samples  357
with sub assemblage information at more than one locus, for example 18S and GDH or  358
18S and ß giardin. The dash between the letters separates the loci information. For  359
example in the column labelled 18S and ß giardin the first sample is B-A2 (2), indicates  360
this sample had assemblage B for 18S and sub-assemblage A2, for ß giardin. The 2 in  361
parentheses indicate there were two samples with this result. A comma between letters  362
e.g. A8, B2 indicates that both genotypes were found in a sample, results written C/D  363
indicates it may have been either C or D.  364
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374
Figure 1 375
Sequencing results for ß giardin. A single peak at a known SNP site indicates a single  376
genotype and possibly a single infection, however two or three peaks may indicate the  377
presence of multiple infections. Samples labeled 238, and 234 have three peaks at a  378
single site. 379
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